EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-World Hospitalization Outcomes with On-Line Hemodiafiltration Versus High-Flux Hemodialysis

Yan Zhang iD, Anke Winter, Linda H Ficociello iD, Belén Alejos Ferrera, Paola Carioni iD, Christian Apel, Otto Arkossy, Michael Anger iD, Robert Kossmann, Len A Usvyat iD, Stefano Stuard iD

Clinical Journal of the American Society of Nephrology · 2026-05 · 21 (5) · 852-859

DOI: 10.2215/cjn.0000000955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 23.12.2025. Verfasst von Yan Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Renal Research Institute, New York, New York. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fresenius Medical Care North America.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Compared with high-flux hemodialysis, postdilution high volume hemodiafiltration was associated with a lower number of hospital admissions. Compared with high-flux hemodialysis, postdilution high volume hemodiafiltration was associated with reduced days spent in the hospital.

Background

Patients with ESKD undergoing hemodialysis experience high rates of hospitalizations and mortality, partly due to the incomplete removal of some toxic uremic molecules. To improve outcomes, multiple modalities of kidney replacement therapy have been developed, including high-flux hemodialysis and on-line hemodiafiltration (HDF). Notably, on-line high-volume HDF (HV-HDF) has demonstrated mortality benefits over high-flux hemodialysis in some randomized trials.

Methods

This retrospective cohort study evaluated hospitalization outcomes among in-center dialysis patients treated with HV-HDF and high-flux hemodialysis at Fresenius Medical Care NephroCare centers across Europe, the Middle East, and Africa between January 2019 and December 2022. Data were extracted from the European Clinical Database. The primary outcome was all-cause hospitalization; secondary outcomes included cause-specific hospitalizations. Negative binomial regression was used to estimate incidence rate ratios (IRRs) for hospital outcomes, incorporating inverse probability of treatment weighting to adjust for baseline differences between treatment groups.

Results

A total of 71,669 patients were included, with 45% receiving hemodialysis and 55% receiving HDF. During the follow-up period, patients in the HDF group underwent a total of 12,741,453 HDF treatments, with a mean convection volume of 25.8 L (84% with CV≥23L). Compared with hemodialysis, treatment with HDF was associated with a lower incidence of both hospital admissions (adjusted IRR, 0.80; 95% confidence interval, 0.79 to 0.82) and days spent in the hospital (adjusted IRR, 0.80; 95% confidence interval, 0.78 to 0.82). These reductions were consistent across subgroups analyzed and across most major causes of hospitalization, including cardiovascular disease, infections, and fluid-related complications.

Conclusions

In this large, real-world cohort spanning multiple regions and dialysis centers, HV-HDF was associated with significantly lower rates of both hospital admissions and days spent in the hospital compared with treatment with high-flux hemodialysis. These findings suggest that HV-HDF may have the potential to reduce morbidity in patients with ESKD.

Schlagwörter

Stichwörter der Autor:innen

hemodialysishospitalization

Autor:innen und Institutionen

  • Renal Research Institute, New York, New York.
  • Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.
  • Fresenius Medical Care, Global Medical Office, Palazzo Pignano, Italy.
  • Fresenius Medical Care Holdings Inc, Waltham, Massachusetts.

ORCID-Profile: Yan Zhang, Linda H Ficociello, Paola Carioni, Michael Anger, Len A Usvyat, Stefano Stuard

Förderung

  • Fresenius Medical Care North America

Zitieren

APA

Zhang, Y., Winter, A., Ficociello, L. H., Ferrera, B. A., Carioni, P., Apel, C., Arkossy, O., Anger, M., Kossmann, R., Usvyat, L. A., & Stuard, S. (2026). Real-World Hospitalization Outcomes with On-Line Hemodiafiltration Versus High-Flux Hemodialysis. Clinical Journal of the American Society of Nephrology, 21(5), 852-859. https://doi.org/10.2215/cjn.0000000955

Vancouver

Zhang Y, Winter A, Ficociello LH, Ferrera BA, Carioni P, Apel C, et al. Real-World Hospitalization Outcomes with On-Line Hemodiafiltration Versus High-Flux Hemodialysis. Clinical Journal of the American Society of Nephrology. 2026;21(5):852-859. doi:10.2215/cjn.0000000955

BibTeX
@article{Zhang2026,
  author = {Zhang, Yan and Winter, Anke and Ficociello, Linda H and Ferrera, Belén Alejos and Carioni, Paola and Apel, Christian and Arkossy, Otto and Anger, Michael and Kossmann, Robert and Usvyat, Len A and Stuard, Stefano},
  title = {Real-World Hospitalization Outcomes with On-Line Hemodiafiltration Versus High-Flux Hemodialysis},
  journal = {Clinical Journal of the American Society of Nephrology},
  year = {2026},
  volume = {21},
  number = {5},
  pages = {852--859},
  doi = {10.2215/cjn.0000000955}
}
Kostenlos starten →